“…Grünewald is supported by grants from the ‘Verein zur Förderung von Wissenschaft und Forschung an der Medizinischen Fakultät der LMU München (WiFoMed)’, by LMU Munich's Institutional Strategy LMUexcellent within the framework of the German Excellence Initiative, the ‘Mehr LEBEN für krebskranke Kinder – Bettina-Bräu-Stiftung’, the Walter Schulz Foundation, the Wilhelm Sander-Foundation (2016.167.1), the Friedrich-Baur foundation, the Matthias-Lackas foundation, the Barbara & Hubertus Trettner foundation, the Dr. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…RESULTS: Complex interaction of social-natural factors (micro-ecology/apartments) are demonstrated by conflicts tenants-lessors (RH-Munich). Conflicts conc. high-rents, luxurious repair, cause dangerous psychoneurological diseases: anxiety-neurosis-insomnia-depression,etc., esp. in patients/seniors with cardio-vascular pathology. …”
Enlace del recurso
Enlace del recurso

Enlace del recurso

Enlace del recurso
Enlace del recurso

“…It has furthermore been shown that two-dimensional linear interpolation using the calibration data allows Alignment monitoring of MDT chambers at the Munich Cosmic-Ray Test-Facility through the use of optical and capacitive alignment systems has been the focus of the studies presented in this thesis. …”
Enlace del recurso

“…(Speaker’s Bureau)University Hospital, LMU Munich (Other Financial or Material Support, Personal fees) Nikolay Klimko, n/a, Astellas (Speaker’s Bureau)Gilead (Speaker’s Bureau)Merck/MSD (Speaker’s Bureau)Pfizer (Speaker’s Bureau) Marisa H. …”
Enlace del recurso
Enlace del recurso

“…(Speaker’s Bureau)University Hospital, LMU Munich (Other Financial or Material Support, Personal fees) Katrien Lagrou, n/a, FUJIFILM WAKO (Speaker’s Bureau)Gilead (Consultant, Speaker’s Bureau)MSD (Consultant, Speaker’s Bureau, Other Financial or Material Support, travel grant)Pfizer (Speaker’s Bureau, travel grant)SMB Laboratoires Brussels (Consultant) Zdenek Racil, n/a, Astellas (Grant/Research Support, Speaker’s Bureau, travel grant) Blandine Rammaert, n/a, Gilead (Speaker’s Bureau, Other Financial or Material Support, travel grant)Merck/MSD (Speaker’s Bureau)Pfizer (Other Financial or Material Support, travel grant) Nikolay Klimko, n/a, Astellas (Speaker’s Bureau)Gilead (Speaker’s Bureau)Merck/MSD (Speaker’s Bureau)Pfizer (Speaker’s Bureau) Sung-Yeon Cho, MD, Gilead (Grant/Research Support, Speaker’s Bureau)Merck Sharp & Dohme (Grant/Research Support, Speaker’s Bureau)Pfizer (Grant/Research Support, Speaker’s Bureau)…”
Enlace del recurso
Enlace del recurso

“…Köhler:  German Federal Ministry of Research and Education and the State of North Rhine-Westphalia, Germany: Other: Support; Miltenyi Biotec GmbH, Bergisch Gladbach, Germany, and the Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, University of Cologne, Cologne, Germany: Other: Non-financial grants; Akademie für Infektionsmedizin e.V., Ambu GmbH, Astellas Pharma, European Confederation of Medical Mycology, Gilead Sciences, GPR Academy Ruesselsheim, MSD Sharp & Dohme GmbH, Noxxon N.V., and University Hospital, LMU Munich: Consultancy, Honoraria. Cornely:  Amplyx, Basilea, BMBF, Cidara, DZIF, EU-DG RTD (101037867), F2G, Gilead, Matinas, MedPace, MSD, Mundipharma, Octapharma, Pfizer, Scynexis: Other: Grants or Contracts. …”
Enlace del recurso
Enlace del recurso

“…Actualmente realiza el proyecto Crónicas desde el exilio entre comunidades exiliadas de la central nuclear de Chernobyl, Ucrania y Fukushima, Japón, así como Lectura de los éxodos, que aborda las trayectorias de refugiados de Medio Oriente y migrantes centroamericanos, auspiciado por el teatro Münchner Kammerspiele de la ciudad de Múnich, Alemania y el Goethe Institut en México. César Antonio Jiménez Rincón Egresado de la Maestría en Artes Escénicas en la Universidad Veracruzana, también tiene estudios de Gestión y Producción Escénica y actuación. …”
Enlace del recurso

“…The analysis based on the nucleotide sequences of the ESBL resistance genes showed that all cefotaximase-Munichs (CTX-Ms) were CTX-M-15 and that all sulfhydryl variables (SHVs) were SHV-11: 41.67% CTX-M-15-producing E. coli, 16.67% CTX-M-15+SHV-11-producing E. coli, 8.33% CTX-M-15-producing K. pneumoniae, 25% CTX-M-15+SHV-11-producing K. pneumoniae, and 8.33% CTX-M-15-produced E. cloacae. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso